产品: COPS5 抗体
货号: DF6602
描述: Rabbit polyclonal antibody to COPS5
应用: WB IHC IF/ICC
文献验证: WB, IHC
反应: Human, Mouse, Rat
预测: Pig, Zebrafish, Bovine, Horse, Sheep, Rabbit, Dog, Chicken, Xenopus
分子量: 37kDa; 38kD(Calculated).
蛋白号: Q92905
RRID: AB_2838564

浏览相似产品>>

   规格 价格 库存
 50ul RMB¥ 1250 现货
 100ul RMB¥ 2300 现货
 200ul RMB¥ 3000 现货

货期: 当天发货

联系销售

产品描述

来源:
Rabbit
应用:
WB 1:500-1:2000, IHC 1:50-1:200, IF/ICC 1:100-1:500
*The optimal dilutions should be determined by the end user.
*Tips:

WB: 适用于变性蛋白样本的免疫印迹检测. IHC: 适用于组织样本的石蜡(IHC-p)或冰冻(IHC-f)切片样本的免疫组化/荧光检测. IF/ICC: 适用于细胞样本的荧光检测. ELISA(peptide): 适用于抗原肽的ELISA检测.

反应:
Human,Mouse,Rat
预测:
Pig(100%), Zebrafish(100%), Bovine(100%), Horse(100%), Sheep(100%), Rabbit(100%), Dog(100%), Chicken(100%), Xenopus(100%)
克隆:
Polyclonal
特异性:
COPS5 Antibody detects endogenous levels of total COPS5.
RRID:
AB_2838564
引用格式: Affinity Biosciences Cat# DF6602, RRID:AB_2838564.
偶联:
Unconjugated.
纯化:
The antiserum was purified by peptide affinity chromatography using SulfoLink™ Coupling Resin (Thermo Fisher Scientific).
保存:
Rabbit IgG in phosphate buffered saline , pH 7.4, 150mM NaCl, 0.02% sodium azide and 50% glycerol. Store at -20 °C. Stable for 12 months from date of receipt.
别名:

展开/折叠

38 kDa Mov34 homolog; COP9 (constitutive photomorphogenic) homolog subunit 5; COP9 constitutive photomorphogenic homolog subunit 5; COP9 signalosome complex subunit 5; COP9 signalosome subunit 5; Cop9 subunit 5; COPS 5; cops5; CSN 5; CSN5; CSN5_HUMAN; JAB 1; Jun activation domain binding protein 1; Jun activation domain binding protein; Jun activation domain-binding protein 1; MGC3149; MOV 34; MOV34; MOV34 family, 38-KD member; SGN 5; SGN5; Signalosome subunit 5;

抗原和靶标

免疫原:
Uniprot:
基因/基因ID:
描述:
The COP9 Signalosome (CSN) is a ubiquitously expressed multiprotein complex that is involved in a vast array of cellular and developmental processes, which is thought to be attributed to its control over the ubiquitin-proteasome pathway. Typically, the CSN is composed of eight highly conserved subunits (CSN1-CSN8), each of which is homologous to one of the eight subunits that form the lid of the 26S proteasome particle, suggesting that these complexes have a common evolutionary ancestor (1). CSN was first identified in Arabidopsis thaliana mutants with a light-grown seedling phenotype when grown in the dark (2-4). The subsequent cloning of the constitutive morphogenesis 9 (cop9) mutant from Arabidopsis thaliana was soon followed by the biochemical purification of the COP9-containing multiprotein complex (4). It is now widely accepted that the CSN directly interacts with cullin-RING ligase (CRL) families of ubiquitin E3 complexes, and that CSN is required for their proper function (5). In addition, CSN may also regulate protein homeostasis through its association with protein kinases and deubiquitinating enzymes. Collectively, these activities position the CSN as a pivotal regulator of the DNA-damage response, cell-cycle control, and gene expression (1). COPS5/CSN5/Jab1 (c-Jun activation domain-binding protein-1) was originally identified as a transcriptional coactivator of c-Jun and subsequently discovered to be a fifth component and integral part of the CSN (6). As the catalytic center of the CSN, COPS5 is able to integrate multiple functions of the CSN complex such as cell-cycle control, transcription, and DNA-damage response by regulating the activity of CRLs through deneddylation of cullins (7).
序列:
MAASGSGMAQKTWELANNMQEAQSIDEIYKYDKKQQQEILAAKPWTKDHHYFKYCKISALALLKMVMHARSGGNLEVMGLMLGKVDGETMIIMDSFALPVEGTETRVNAQAAAYEYMAAYIENAKQVGRLENAIGWYHSHPGYGCWLSGIDVSTQMLNQQFQEPFVAVVIDPTRTISAGKVNLGAFRTYPKGYKPPDEGPSEYQTIPLNKIEDFGVHCKQYYALEVSYFKSSLDRKLLELLWNKYWVNTLSSSSLLTNADYTTGQVFDLSEKLEQSEAQLGRGSFMLGLETHDRKSEDKLAKATRDSCKTTIEAIHGLMSQVIKDKLFNQINIS

种属预测

种属预测:

score>80的预测可信度较高,可尝试用于WB检测。*预测模型主要基于免疫原序列比对,结果仅作参考,不作为质保凭据。

Species
Results
Score
Pig
100
Horse
100
Bovine
100
Sheep
100
Dog
100
Xenopus
100
Zebrafish
100
Chicken
100
Rabbit
100
Model Confidence:
High(score>80) Medium(80>score>50) Low(score<50) No confidence

翻译修饰 - Q92905 作为底物

Site PTM Type Enzyme
A2 Acetylation
K11 Ubiquitination
S24 Phosphorylation
K30 Ubiquitination
K33 Ubiquitination
K34 Ubiquitination
K43 Ubiquitination
K47 Acetylation
K47 Ubiquitination
K53 Ubiquitination
Y54 Phosphorylation
K56 Ubiquitination
S58 Phosphorylation
S71 Phosphorylation
Y120 Phosphorylation
K125 Ubiquitination
K180 Ubiquitination
K191 Ubiquitination
K194 Ubiquitination
Y203 Phosphorylation
K210 Ubiquitination
K236 Ubiquitination
Y261 Phosphorylation
R282 Methylation
S284 Phosphorylation
R294 Methylation
K295 Methylation
K309 Ubiquitination
S320 Phosphorylation
K324 Ubiquitination
K326 Acetylation
K326 Ubiquitination

研究背景

功能:

Probable protease subunit of the COP9 signalosome complex (CSN), a complex involved in various cellular and developmental processes. The CSN complex is an essential regulator of the ubiquitin (Ubl) conjugation pathway by mediating the deneddylation of the cullin subunits of the SCF-type E3 ligase complexes, leading to decrease the Ubl ligase activity of SCF-type complexes such as SCF, CSA or DDB2. The complex is also involved in phosphorylation of p53/TP53, c-jun/JUN, IkappaBalpha/NFKBIA, ITPK1 and IRF8, possibly via its association with CK2 and PKD kinases. CSN-dependent phosphorylation of TP53 and JUN promotes and protects degradation by the Ubl system, respectively. In the complex, it probably acts as the catalytic center that mediates the cleavage of Nedd8 from cullins. It however has no metalloprotease activity by itself and requires the other subunits of the CSN complex. Interacts directly with a large number of proteins that are regulated by the CSN complex, confirming a key role in the complex. Promotes the proteasomal degradation of BRSK2.

细胞定位:

Cytoplasm>Cytosol. Nucleus. Cytoplasm>Perinuclear region. Cytoplasmic vesicle>Secretory vesicle>Synaptic vesicle.
Note: Nuclear localization is diminished in the presence of IFIT3.

Extracellular region or secreted Cytosol Plasma membrane Cytoskeleton Lysosome Endosome Peroxisome ER Golgi apparatus Nucleus Mitochondrion Manual annotation Automatic computational assertionSubcellular location
亚基结构:

Component of the CSN complex, composed of COPS1/GPS1, COPS2, COPS3, COPS4, COPS5, COPS6, COPS7 (COPS7A or COPS7B), COPS8 and COPS9 isoform 1. In the complex, it probably interacts directly with COPS1, COPS2, COPS4, COPS6 and COPS7 (COPS7A or COPS7B) and COPS9 isoform 1. Interacts with COPS9 isoform 2. The CSN complex interacts with the BRISC complex. Also exists as monomeric form. Interacts with TP53, MIF, JUN, UCHL1, NCOA1, HIF1A, CDKN1B, BCL3, GFER, PGR, LHCGR, SMAD4, SMAD7, ID1, ID3, ITGB2 and TOP2A. Part of a complex consisting of RANBP9, Ran, DYRK1B and COPS5. Interacts with IFIT3. Interacts with BRSK2. Interacts with ZDHHC16. Interacts with MINDY3. Interacts with FANK1; regulates the phosphorylation of JUN and the transcriptional activity of AP-1. Interacts with NUPR1; this interaction allows COPS5-dependent CDKN1B nuclear to cytoplasm translocation.

蛋白家族:

The JAMM motif is essential for the protease activity of the CSN complex resulting in deneddylation of cullins. It constitutes the catalytic center of the complex (By similarity).

Belongs to the peptidase M67A family. CSN5 subfamily.

文献引用

1). Calcium Channel Blocker Nifedipine Suppresses Colorectal Cancer Progression and Immune Escape by Preventing NFAT2 Nuclear Translocation. , 2020

Application: WB    Species: Human    Sample: SW620 cells

Figure 5. NFAT2 Recruits Phosphorylated STAT3 to Elevate the Expression of Downstream Effectors (A) The colocalization of p-STAT3 (green) and NFAT2 (red) in control and LASP1-overexpressing SW620 cells was assessed by IF staining. The scale bar represents 50 mm. (B) Analysis of the correlation between NFAT2 and p-STAT3 in clinical tissues with high and low expression of NFAT2 by IHC staining. The right panel presents the percentage of patients with high or low expression of CRC tissue. Scale bar represents 50 mm. (C) Endogenous interaction between NFAT2 and p-STAT3 in control and LASP1-overexpressing SW620 cells. (D) Endogenous interaction between NFAT2 and p-STAT3 in SW620 cells after treatment with NIFE or BAY was detected by coIP assays. (E) The transcriptional regulation of the downstream genes COPS5, TWIST1, MMP2, and PD-L1 by NFAT2 and p-STAT3 was detected by ChIP assays. (F) The binding sites between NFAT2 and the downstream genes were confirmed by a dual-luciferase reporter system. (G) Left panel: the expression of NFAT2 and downstream genes in control and NIFE-treated SW620 cells were detected by qPCR. Right panel: the expression alterations in downstream genes in the indicated cells treated with NIFE or BAY were detected by WB. (H) The relationship between NFAT2 and downstream genes was detected from the GEO database. (I) IHC analysis was performed to detect the expression of NFAT2, TWIST1, COPS5, and MMP2 in human CRC tissues. Two representative cases are shown. Percentage of patients with high or low expression of CRC tissue on the right panel. Scale bar represents 50 mm. (G) After treating SW620 cells with CsA (10 mM), VIVIT (10 mM), and FK506 (10 ng/mL) and subsequently separating the nuclear and cytoplasmic proteins, WB analysis was used to detect the level of NFAT2 in the nucleus and p-NFAT2 in the cytoplasm. (H) Representative images of IHC staining analysis of NFAT2 expression in CRC tissues and adjacent nontumor tissues. The bar chart on the right represents the percentage of high and low NFAT2 expression cases in normal and CRC tissues. (I) IHC analysis of NFAT2 and p-NFAT2 expression in nonmetastatic and metastatic CRC tissues. The bar chart on the right represents the percentage of high and low NFAT2 or p-NFAT2 expression cases in nonmetastatic CRC and metastatic CRC tissues.

Application: IHC    Species: Human    Sample: SW620 cells

Figure 5. NFAT2 Recruits Phosphorylated STAT3 to Elevate the Expression of Downstream Effectors (A) The colocalization of p-STAT3 (green) and NFAT2 (red) in control and LASP1-overexpressing SW620 cells was assessed by IF staining. The scale bar represents 50 mm. (B) Analysis of the correlation between NFAT2 and p-STAT3 in clinical tissues with high and low expression of NFAT2 by IHC staining. The right panel presents the percentage of patients with high or low expression of CRC tissue. Scale bar represents 50 mm. (C) Endogenous interaction between NFAT2 and p-STAT3 in control and LASP1-overexpressing SW620 cells. (D) Endogenous interaction between NFAT2 and p-STAT3 in SW620 cells after treatment with NIFE or BAY was detected by coIP assays. (E) The transcriptional regulation of the downstream genes COPS5, TWIST1, MMP2, and PD-L1 by NFAT2 and p-STAT3 was detected by ChIP assays. (F) The binding sites between NFAT2 and the downstream genes were confirmed by a dual-luciferase reporter system. (G) Left panel: the expression of NFAT2 and downstream genes in control and NIFE-treated SW620 cells were detected by qPCR. Right panel: the expression alterations in downstream genes in the indicated cells treated with NIFE or BAY were detected by WB. (H) The relationship between NFAT2 and downstream genes was detected from the GEO database. (I) IHC analysis was performed to detect the expression of NFAT2, TWIST1, COPS5, and MMP2 in human CRC tissues. Two representative cases are shown. Percentage of patients with high or low expression of CRC tissue on the right panel. Scale bar represents 50 mm. (G) After treating SW620 cells with CsA (10 mM), VIVIT (10 mM), and FK506 (10 ng/mL) and subsequently separating the nuclear and cytoplasmic proteins, WB analysis was used to detect the level of NFAT2 in the nucleus and p-NFAT2 in the cytoplasm. (H) Representative images of IHC staining analysis of NFAT2 expression in CRC tissues and adjacent nontumor tissues. The bar chart on the right represents the percentage of high and low NFAT2 expression cases in normal and CRC tissues. (I) IHC analysis of NFAT2 and p-NFAT2 expression in nonmetastatic and metastatic CRC tissues. The bar chart on the right represents the percentage of high and low NFAT2 or p-NFAT2 expression cases in nonmetastatic CRC and metastatic CRC tissues.

限制条款

产品的规格、报价、验证数据请以官网为准,官网链接:www.affbiotech.com | www.affbiotech.cn(简体中文)| www.affbiotech.jp(日本語)

产品的数据信息为Affinity所有,未经授权不得收集Affinity官网数据或资料用于商业用途,对抄袭产品数据的行为我们将保留诉诸法律的权利。

产品相关数据会因产品批次、产品检测情况随时调整,如您已订购该产品,请以订购时随货说明书为准,否则请以官网内容为准,官网内容有改动时恕不另行通知。

Affinity保证所销售产品均经过严格质量检测。如您购买的商品在规定时间内出现问题需要售后时,请您在Affinity官方渠道提交售后申请。

产品仅供科学研究使用。不用于诊断和治疗。 

产品未经授权不得转售。

Affinity Biosciences将不会对在使用我们的产品时可能发生的专利侵权或其他侵权行为负责。Affinity Biosciences, Affinity Biosciences标志和所有其他商标所有权归Affinity Biosciences LTD.